Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial

BACKGROUND: Natural products may provide a source for the discovery and development of adjunctive pharmacological interventions to modulate the inflammatory pathways contributing to chronic disease. Xanthohumol, a flavonoid from the hops plant (Humulus lupulus), has antioxidant and anti-inflammatory...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Trials
Auteurs principaux: Bradley, Ryan, Langley, Blake O., Ryan, Jennifer J., Phipps, John, Hanes, Douglas A., Stack, Emily, Jansson, Janet K., Metz, Thomas O., Stevens, Jan Frederik
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Study Protocol
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7542976/
https://ncbi.nlm.nih.gov/pubmed/33028396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04769-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires